Discussion
Vyvgart (efgartigimod alfa-fcab) and Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) are now approved in the U.S. to treat all adults with generalized myasthenia gravis (gMG), regardless of antibody status. The U.S. Food…